Analyst Ratings February 12, 2026

BTIG Lifts Scorpio Tankers Price Target to $85; Mixed Analyst Views Keep Spotlight on Cash Returns

Strong forward bookings, improving cash position and continued buybacks underpin bullish view even as other firms voice caution

By Marcus Reed STNG
BTIG Lifts Scorpio Tankers Price Target to $85; Mixed Analyst Views Keep Spotlight on Cash Returns
STNG

BTIG raised its price target for Scorpio Tankers (NYSE:STNG) to $85 from $80 while keeping a Buy rating, citing robust forward bookings and improving rate momentum. The company reported EBITDA roughly in line with expectations, enhanced its dividend and returned material cash to shareholders this quarter. Scorpio also moved to a pro forma net cash position and announced the sale of an LR2 product tanker. At the same time, competing analyst views are mixed, with BofA downgrading the stock and other BTIG coverage assigning a different near-term target.

Key Points

  • BTIG raised its price target for Scorpio Tankers to $85 from $80 and kept a Buy rating; the stock is trading near its 52-week high and is up 37.5% year-to-date.
  • Scorpio reported EBITDA of roughly $132 million in line with estimates, with forward bookings showing about 70% of LR2 days fixed at ~$43,000 and about 63% of MR days fixed at ~$32,000.
  • The company moved to a pro forma net cash position of $382.7 million as of January 2026, announced the sale of LR2 vessel STI Kingsway for $57.5 million, and continues to return cash via dividends and buybacks.

BTIG on Thursday raised its price objective for Scorpio Tankers (NYSE:STNG) to $85.00 from $80.00 and maintained a Buy rating on the shares. The upgrade comes as the stock is trading near its 52-week high of $70.96 and has produced a year-to-date gain of 37.5%. InvestingPro data cited in coverage describes the shares as appearing slightly undervalued relative to a Fair Value assessment.

On the operating front, Scorpio reported EBITDA of approximately $132 million, aligned with Street expectations. Management’s forward bookings for the company’s spot fleet show meaningful coverage: roughly 70% of LR2 days are fixed at about $43,000 and roughly 63% of MR days are locked in at about $32,000. These forward booking levels sit above the fleet’s recent spot performance in the fourth quarter, when LR2s averaged about $34,000 and MRs averaged about $24,000.

BTIG highlighted regional differences in MR performance, noting current averages near $41,000 in the Atlantic and about $26,000 in the Pacific. Those figures were presented alongside InvestingPro’s assessment of Scorpio’s financial profile, which is rated as "GREAT," with a P/E ratio of 11.71 and gross profit margins of 62.7%.


Shareholder returns remain a focus. Scorpio increased its quarterly dividend by roughly 7% to $0.45 per share, equating to an approximate 3% annualized yield. During the quarter the company returned about $22 million to shareholders, representing roughly 18% of operating cash flow. BTIG pointed out that a majority of Q1 spot trading days were fixed at levels above the Q4 baseline and that current spot rates are exceeding quarter-to-date bookings.

On that basis the research firm contends Scorpio is positioned to continue returning cash to shareholders. The company has about $173 million remaining under its share buyback program, and management has been actively repurchasing stock, an action noted as a positive indicator by InvestingPro.


Scorpio’s balance sheet developments were highlighted as well. The company reported a pro forma net cash position of $382.7 million as of January 2026, in contrast to a net debt position of $293.4 million as of September 2025. In connection with a fleet adjustment strategy, Scorpio announced the sale of its LR2 product tanker, STI Kingsway, for $57.5 million. That sale is expected to close in the first or second quarter of 2026.

Analyst views beyond BTIG show some divergence. BofA Securities downgraded Scorpio from Buy to Underperform and reduced its price target to $53.00, citing concerns that earnings may be approaching peak levels. Separately, another BTIG note maintained a Buy rating but listed a $75.00 price target for the company, pointing to strong market conditions and increased timecharter activity.

Peer and market context was also referenced in coverage: International Seaways received a BTIG price target boost to $70.00 from $60.00 while keeping a Buy rating, an adjustment attributed to crude tanker spot rates that have materially outperformed expectations, with VLCC spot rates averaging $100,000 year-to-date.


Taken together, BTIG’s move to raise its price target to $85 reflects confidence in near-term rate momentum, forward booking coverage and an improving balance sheet that supports dividends and buybacks. At the same time, contrasting analyst opinions and the potential for rates to pass a peak underscore remaining uncertainty in the tanker cycle.

Risks

  • Divergent analyst views: BofA downgraded the stock to Underperform and cut its target to $53, citing concerns that earnings may be near peak levels - this introduces near-term downside risk for equity investors and impacts shipping sector sentiment.
  • Rate volatility: Although forward bookings and current rates exceed Q4 levels, the tanker market remains exposed to spot rate swings which could reduce profitability and cash return capacity, affecting energy and shipping markets.
  • Execution and timing of fleet transactions: The STI Kingsway sale and other fleet adjustments are expected to close in Q1 or Q2 2026; timing or execution risks around these transactions could affect reported cash and balance sheet metrics.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026